Artiva Biotherapeutics, Inc. 4

Insider Jennifer Bush received 45,000 RSU shares and 135,000 stock options of Artiva Biotherapeutics, Inc. as equity compensation.

On September 9, 2026, Artiva Biotherapeutics, Inc. COO/CLO/Compliance Officer Jennifer Bush received equity-based compensation in the form of 45,000 shares of common stock via restricted stock units and an employee stock option for 135,000 shares at an exercise price of $10.79 per share under the issuer’s 2024 Equity Incentive Plan, with the option vesting in equal monthly installments over four years beginning September 8, 2026. Following these awards, her direct ownership of common stock increased to 374,529 shares, and she also holds the newly granted 135,000 stock options, significantly expanding her equity stake in the company.

Filing Facts

CIK

1817241

Ticker

ARTV

Form

4

Source Type

fda

Accession

0001193125-26-389511

Alert Tier

5